Skip to content
Catalyst

PapersPMID:28431534

The effects of Spirulina Platensis on anthropometric indices, appetite, lipid profile and serum vascular endothelial growth factor (VEGF) in obese individuals: a randomized double blinded placebo controlled trial.

BMC complementary and alternative medicine2017The record ↗

findings
2
compound
1
endpoints
2
no difference found
1
  1. Finding, moderate evidencelowersBody mass index
  2. Finding, moderate evidenceno difference foundHDL cholesterol
Study, every finding
RCT · 3 months
Dose studied, every finding
500 mg twice daily (1 g/day)
Population, every finding
Obese adults aged 20 to 50 years (BMI 30 or above); 56 completers; placebo was starch pills
  • “BMI had significantly decreased in both groups and its mean reduction in Spirulina platensis-treated group was significantly higher compared with placebo-treated group.”

What did not

  • “HDL significantly increased in both intervention and control group (P < 0.05), although mean differences of change in serum HDL-c between groups were not significant (P = 0.514).”

Study record

Design
randomised controlled trial
Species
human
Population
Obese individuals aged 20-50 years, BMI of 30 kg/m2 or more
Participants
56
Comparator
placebo
Duration
84 days
Endpoints measured
31